Screener
Adaptive Biotechnologies ADPT Mrd Business — General And Administrative Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Adaptive Biotechnologies in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The source filing: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:30 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206546
| Line item | Three Months Ended March 31, 2026 / MRD | Three Months Ended March 31, 2026 / Immune Medicine | Three Months Ended March 31, 2026 / Total | Three Months Ended March 31, 2025 / MRD | Three Months Ended March 31, 2025 / Immune Medicine(1) | Three Months Ended March 31, 2025 / Total |
|---|---|---|---|---|---|---|
| Cost of revenue | 17,244 | * | 17,244 | 15,885 | * | 15,885 |
| Research and development | 9,226 | 13,934 | 23,160 | 9,159 | 14,488 | 23,647 |
| Sales and marketing | 24,742 | * | 24,742 | 21,413 | * | 21,413 |
| General and administrative | 12,519 | * | 12,519 | 9,502 | * | 9,502 |
| Other segment items(2) | — | 5,776 | 5,776 | — | 5,153 | 5,153 |
| Add back: | ||||||
| Items to reconcile net income or net loss to Adjusted EBITDA(3) | 8,776 | 5,569 | 14,345 | 8,127 | 5,813 | 13,940 |
| Adjusted EBITDA(3) | 12,138 | (10,360) | 1,778 | (4,111) | (5,106) | (9,217) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Adaptive Biotechnologies's mrd business — general and administrative expense?
- Adaptive Biotechnologies (ADPT) reported mrd business — general and administrative expense of $12.52M in Q1 2026.
- How has Adaptive Biotechnologies's mrd business — general and administrative expense changed year-over-year?
- Adaptive Biotechnologies's mrd business — general and administrative expense increased by 31.8% year-over-year, from $9.5M to $12.52M.
- What is the long-term trend for Adaptive Biotechnologies's mrd business — general and administrative expense?
- Over 3 years (2022 to 2025), Adaptive Biotechnologies's mrd business — general and administrative expense has grown at a 9.2% compound annual growth rate (CAGR), from $32.35M to $42.08M.
- What does mrd business — general and administrative expense mean?
- This includes the overhead costs, such as legal, human resources, and executive management, allocated to the MRD business segment. It reflects the operational efficiency and administrative burden required to support the segment's core business activities.
Ask your AI about Adaptive Biotechnologies's mrd business — general and administrative expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude